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Abstract: Microarray data measured by microarray are useful for cancer classification. 
w. 
However, it faces with several problems in selecting genes for the classification due to many & 
irrelevant genes, noisy data, and the availability of a small number of samples compared to a 
huge number of genes (high-dimensional data). Hence, this paper proposes a two-stage gene 
selection method to select a smaller (near-optimal) subset of informative genes that is most 
relevant for the cancer classification. It has two stages: 1) pre-selecting genes using a filter 
method to produce a subset of genes; 2) optimising the gene subset using a multi-objective 
hybrid method to automatically yield a smaller subset of informative genes. Two microarray 
data sets are used to test the effectiveness of th'e proposed method. Experimental results show 
that the performance of the proposed method is superior to other experimental methods and 
related previous works. 
Keywords: Cancer Classification, Filter Method, Gene Selection, Genetic Algorithm, Hybrid 
Method, Microarray Data. 
1. INTRODUCTION 
Microarray technology is used to measure the expression levels of thousands of genes 
simultaneously, and finally produce microarray data. A comparison between the gene 
expression levels of cancerous and normal tissues can also be done. This comparison is useful 
to select those genes that might anticipate the clinical behaviour of cancers. Thus, there is a 
need to select informative genes that contribute to a cancerous state. However, the gene 
selection poses a major challenge because of the following characteristics of microarray data: 
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• High-dimensional data, for example, a huge number of genes and a small number of 
samples are in the ranges of7,000-15,000 and 30-200, respectively. 
• Most genes are not relevant for classifying different tissue types. 
• These data have noisy genes. 
To overcome the problems, a gene selection method is used to select a subset of 
genes that maximises the classifier's ability to classify samples more accurately. The gene 
selection method has several advantages such as improving classification accuracy, reducing 
the dimensionality of data, and removing irrelevant and noisy genes. 
In the context of cancer classification, gene selection methods can be classified into 
two categories. If a gene selection method is carried out independently from a classifier, it 
belongs to the filter approach. Otherwise, it is said to follow a ·hybrid (wrapper) approach. In 
the early era of microarray analysis, most previous works have used the filter approach to 
select genes since it is computationally more efficient than the hybrid method [9]. However, 
the hybrid approach usually provides greater accuracy than the filter approach. Until now, 
several hybrid methods [2-7], especially a combination between a genetic algorithm (GA) [l] 
and a support vector machine (SVM) [8] classifier (GASVM), have been implemented to 
select informative genes. Generally, our previous hybrid methods, i.e., GASVM-based 
methods performed well in high-dimensional data since we proposed a modified chromosome 
representation, a cyclic approach, and a multi-objective strategy [3-6]. However, the methods 
yielded inconsistent results when they were run independently. 
The previous work of [2] that proposed GASVM-based methods can simultaneously 
optimise genes and SVM parameter settings. The work of [7] introduced a recursive feature 
elimination post-processing step after the step of a GASVM-based method in order to reduce 
the number of selected genes again. Nevertheless, the hybrid methods (GASVM-based 
methods) of the previous works are intractable to efficiently produce a smaller subset of genes 
in high-dimensional data due to their binary chromosome representation drawback [2],[7]. 
The total number of gene subsets produced by the GASVM-based methods in the previous 
2Mworks are calculated by Me = -1 where Me is the total number of subsets, whereas M is 
the total number of genes. Based on this equation, the GASVM-based methods are almost 
impossible to evaluate all possible subsets of selected genes if M is too many (high-
dimensional data). Although the work of [7] implemented a pre-processing step to decrease 
the dimensionality of data, but it can only reduce a small number of genes, and many genes 
are still available in the data. The GASVM-based methods [2],[7] also face with the high risk 
of over-fitting problems. An over-fitting problem is happened because the number of genes 
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r of greatly exceeds the number of samples. The over-fitting problem that occurred on hybrid 
methods (e.g., GASVM-based methods) is also reported in a review paper in [9]. 
In order to solve the problems derived from microarray data and overcome the 
limitation of the GASVM-based methods in the previous works [2-7], we propose a two-stage 
gene selection method (Filter+MOGASVM). This proposed method is able to perfonn well in 
. high-dimensional data and reduce a risk of over-fitting problems since it has two stages as 
follows: stage 1 to decrease the dimensionality of data; stage 2 to produce a smaller (near-
optimal) genes subset. The diagnostic goal is to develop a medical procedure based on the 
least number of possible genes that needed to detect diseases. Thus, the ultimate goal of this 
paper is to select a smaller subset of informative genes (minimise the ntnnber of selected 
genes) for yielding higher cancer classification accuracy (maximise the classification 
accuracy). To achieve the goal, we adopt Filter+MOGASVM. The proposed method is 
evaluated on two real microarray data sets of tumour samples. 
The outline of this paper is as follows: Section 2 discusses the detail of the proposed 
Filter+MOGASVM. In Section 3, microarray data sets used, experimental setup, and 
experimental results are described. The conclusion of this paper is provided in Section 4. 
2. THE PROPOSED TWO-STAGE GENE SELECTION METHOD 
(FILTER+MOGASVM) 
In this paper, we propose Filter+MOGASVM to overcome the drawbacks of GASVM-based 
methods in the related previous works [2-7]. Filter+MOGASVM in our work differs from the 
methods in the previous works in one major part. The major difference is that our proposed 
method involves two stages (using a filter method and a hybrid method), whereas the previous 
works usually used only one stage (using a hybrid method) for gene selection. The difference 
is necessary in order to produce a smaller (near-optimal) gene subset from high-dimensional 
data and reduce the high risk of over-fitting problems. For more understanding, the general 
flowcharts of our work and the previous works are shown in Fig. I (a) and Fig. I (b), 
respectively. The detailed stages ofFilter+MOGASVM are described as follows. 
2.1 Stage 1: Pre-Selecting Genes Using a Filter Method 
In the first stage, we apply a filter method such as gain ratio (GR) or infonnation gain (IG) on 
the training set to pre-select genes and finally produce a subset of genes. After the pre-select 
process, the dimensionality of data is also decreased. The filter method calculates and ranks a 
score for each gene. Genes with the highest scores are selected and put into the gene subset. 
This subset is used as an input to the second stage. 
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(independent selSince GASVM-based methods in previous works performs poorly in high-
from combinatildimensional data, and meanwhile, we use a GASVM-based method (MOGASVM) in the 
methods are GRsecond stage of Filter+MOGASVM, a filter method (GR or IG) in this frrst stage is used to 
reduce the high-dimensional in order to overcome the drawback of GASVM-based methods. 
3. EXPERIMEIf the subset that produced by the filter method is small-dimension, the combination of genes 
is not complex, and then MOGASVM in the next stage can possible to produce a smaller 
3.1 Data Sets (near-optimal) subset of informative genes. 
Two benchmark 
Gene expression data 
(training set) evaluate Filter+: 
f-------------~--~-~-~-~-~-~-~--~~-~-~-~-~-~-~--~------------------I -----------------------
: Gene : 
: Stage 1: Selecting genes by using a hybrid selection : Stage 1: Pre-selecting genes by using gain Data set Number of 
: method (e.g., GASVM-based methods) method : ratio or information gain 
classes 
I I 
I I Lung 2 (MPMand: A subset of genes : 
1 1 
ADCA)I I 
Stage 2: Optimising the gene subset by MLL 3 (ALL, MLLTest set Cancer classification by using MOGASVM 
using an SVM classifier andAML) 
Note:A smaller (near-optimal) subset of MPM = malignant pleural mescinformative genes ALL = acute lymphoblastic leu 
Test set 3.2 Experimel 
Figure I. General flowcharts of (a) previous works (GASVM-based methods); (b) our work Since the num! 
(Filter+MOGASVM). accuracy on tl 
accuracy, a cll 
2.2 Optimizing a Gene Subset Using MOGASVM from the test 
estimated by tI 
In this stage, we develop and use MOGASVM to automatically optimise the gene test set. 
subset that is produced by the frrst stage, and finally yield a smaller (near-optimal) subset of Table 
informative genes. This smaller subset is identified by an evaluation function in MOGASVM based on the 
that uses two criteria: maximisation of the leave-one-out-cross-validation (LOOeV) accuracy considered to 
and minimisation of the number of selected genes. MOGASVM selects and optimises genes methods [2-7 
by considering relations among them in order to remove irrelevant and noisy genes. The accuracies an 
smaller subset is possible to be found due to the dimensionality and complexity of data has performance. 
been frrstly reduced by the first stage. The high risk of over-fitting problems can be also proposed met 
decreased because of the reduction. The detail of MOGASVM can be found in [4]. 10 times on f 
Finally, the smaller subset of the training set is used to construct an SVM classifier GASVM (siJ 
for cancer classification, and the constructed SVM is then tested by using the test set 
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(independent set). This paper has produced two methods of Filter+MOGASVM obtained 
from combinations of two different filter methods (GR and IG) and MOGASVM. These 
methods are GR+MOGASVM and IG+MOGASVM. 
3. EXPERIMENTS 
3.1 Data Sets 
Two benchmark microarray data sets that contain binary classes and multi-classes are used to 
evaluate Filter+MOGASVM. It is summarised in Table 1. 
Table 1. The summary ofmicroarray data sets. 
Dataset Number of Number of samples Number of samples Number Source 
classes in the training set in the test set of genes 
Lung 2(MPM and 32 (16 MPM and 16 149 (15 MPM and 12,533 http://chestsurg.orglpublica 
ADCA) ADCA) 134ADCA tions/2002-
microarray.aspx 
MLL 3 (ALL, MLL, 57 (20 ALL, 17 15 (4 ALL, 3 MLL, 12,582 http://www.broad.mit.edu/ 
andAML) MLL, and 20 AML) and 8 AML) cgi-binlcancer/datasets.cgi 
Note: 
MPM = malignant pleural mesothelioma. MLL = mixed-lineage leukaemia. ADCA = adenocarcinoma. 
ALL = acute lymphoblastic leukaemia. AML = acute myeloid leukaemia. 
3.2 Experimental Setup 
Since the number of training samples in microarray data is small, the cross-validation (CV) 
accuracy on the training set is calculated through an LOOCV procedure [3]. For the test 
accuracy, a classifier is built using all the training samples, and the classes of test samples 
from the test set are predicted one by one using the built classifier. The test accuracy is 
estimated by the number of the correctly classified, divided by the number of samples in the 
test set. 
Table 2 contains parameter values for Filter+MOGASVM. These values are chosen 
based on the results of preliminary runs. Three criteria following their importance are 
considered to evaluate and compare the performance of Filter+MOGASVM with existing 
methods [2-7]: test accuracy, CV accuracy, and the number of selected genes. Higher 
accuracies and a smaller number of selected genes are needed to obtain an excellent 
performance. The top 200 genes are pre-selected by using GR and IG in the first stage of the 
proposed method, and are then used for the second stage. Several experiments are conducted 
10 times on each data set using Filter+MOGASVM and other experimental methods such as 
GASVM (single-objective), MOGASVM, GASVM version 2 (GASVM-II), and SVM. 
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Filter+GASVM methods (IG+GASVM and GR+GASVM) are also experimented for the Table 4. C 
comparison. Next, an average result of the 10 independent runs is obtained. 
Run# 
Table 2. Parameter Settings for Filter+MOGASVM. I 
2 
3 
Parameter Lung Data Set MLL Data Set 
Size of population 100 100 
4Number of generation 300 300 
5Crossover rate 0.7 0.7 
6Mutation rate 0.01 0.01 
7Weight I, WI 0.7 0.7 
8 
Weight 2, w2 0.3 0.3 9 
Cost for SVM 0.7 100 10 
Average 
±S.D.3.3 Experimental Results 
3.3.2 Filter+M 
3.3.1 LOOCV and test accuracies of selected genes with Filter+MOGASVM 
The b~ 
Tables 3 and 4 show the results for each run on the lung and MLL data sets, respectively. The 
methods that h 
results of the best subsets are shown in shaded cells, whereas the results in boldface display 
LOOCV and tl 
the best result of averages. S.D. denotes the standard deviation. Run# and #Genes represent a 
Filter+GASVM 
run number and a number of selected genes, respectively. Almost all runs have achieved 
selected genes I 
100% LOOCV accuracy on all the data sets. This has proved that Filter+MOGASVM has 
Based 
efficiently selected and produced a near-optimal gene subset from a solution space. 
of selected gen 
methods exceJ 
Table 3. Classification accuracies using Filter+MOGASVM on the lung data set. 
deviations in al 
GR+MOGASVM IG+MOGASVM 
between LOoe Run# (Filter+MOGASVM) (Filter+MOGASVM) 
LOOCV (%) Test (%) #Genes LOOCV (%) Test (%) #Genes lower. This sm 
I 10Q 98.66 2 100 97.99 2 ;.1' other hand, thl 
2 100 94.63 2 100 96.64 2 
accuracy becal 3 100 95.30 2 100 97.32 2 
4 100 97.32 2 100 97.32 2 
" i fitting is a maj 
5 100 95.97 2 100 94.63 2 data when the 6 100 97.99 2 100 95.30 2 
7 100 95.97 2 100 95.30 2 
8 100 95.97 2 100 95.97 2 
9 100 95.97 2 100 99.33 2 
10 100 93.96 2 100 93.29 2 
Average 100 96.18 2 100 96.31 2 
±S.D. ± 0 ± 1.45 ± 0 ±O ±1.77 ±O 
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Table 4. Classification accuracies using Filter+MOGASVM on the MLL data set. 
GR+MOGASVM IG+MOGASVM 
Run# (Filter+MOGASVM) (Filter+MOGASVM) 
LOOCV (%) Test (%) #Genes LOOCV (%) Test (%) #Genes 
1 100 93.33 6 100 93.33 7 
2 100 93.33 6 100 93.33 6 
3 100 100 5 100 100 7 
4 100 93.33 7 98.25 100 6 
5 100 100 5 100 93.33 7 
6 100 93.33 6 100 93.33 5 
7 lela 100 5 100 100 7 
8 100 100 7 100 100 6 
9 ronrf~ 5 IOn fOO 5 
10 100 93.33 4 100 86.67 7 
Average 100 96.67 5.60 99.83 96.00 6.30 
±S.D. :I: 0 :I: 3.51 ± 0.97 ± 0.56 ± 4.66 ± 0.82 
3.3.2 Filter+MOGASVM versus other experimental methods 
The benchmark of Filter+MOGASVM in comparison with other experimental 
methods that have been experimented in this work is summarized in Table 5. Overall, the 
LOOCV and test accuracies of Filter+MOGASVM for all the data sets were higher than 
Filter+GASVM, MOGASYM, GASVM-lI, GASVM, and SVM. Moreover, the number of 
selected genes by using Filter+MOGASVM was also lower. 
Based on the standard deviations of LOOCV accuracy, test accuracy, and the number 
of selected genes, Filter+MOGASVM was also more consistent than the other experimental 
methods except the SVM classifier. This SVM classifier achieved 0 for the standard 
deviations in all experiments since it did not implement any gene selection approach. The gap 
between LOOCV accuracy and test accuracy that resulted by Filter+MOGASVM was also 
lower. This small gap shows that the risk of the over-fitting problem can be reduced. On the 
other hand, the results of LOOCV accuracy of the others were much higher than their test 
accuracy because they were unable to avoid or reduce the risk of over-fitting problems. Over-
fitting is a major problem of hybrid methods in gene selection and classification of microarray 
data when the classification accuracy on training samples, e.g., LOOCV accuracy is much 
higher than the test accuracy. 
GASVM and MOGASVM cannot produce a near-optimal subset of informative 
genes because they perform poorly in high-dimensional data due to their chromosome 
representation drawback. GASVM-II method is impractical to be used in real applications 
because a variety number of selected genes should be tested in order to obtain the near-
optimal one. On the contrary, the proposed Filter+MOGASVM that pre-selects a number of 
genes in the first stage can automatically optimise the selected genes by the second stage in 
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order to remove irrelevant genes and produce a smaller (near-optimal) subset of informative 
genes. 
Table 5. The benchmark of Filter+MOGASVM with Filter+GASVM and the previous 
methods on the lung and MLL data sets. 
Lung Data Set (Average ± S.D.; The MLL Data Set (Average ± S.D.; 
Best) The Best) Method 
Accuracy (%) #Genes Accuracy (%)#Genes 
LOOCV Test LOOCV Test 
GR+MOGASVM 2 ± 100 ± 96.18 ±S,6t)·;!:. . lOll:!: 96.67 ± 
_Ec~lter+~ndA~v~..__ 0; 2 0; 100 1.45; 98.66 EF;91~R ~ O; !~K_ .._~K:!~!;_l~_K 
IG+MOGASVM 2±100 :Ii 9Ui1* 6.30 ± 99.83 ± 96.00 ± 
..~i!!K~MldApsMF 0;2 0;1'00 1"rb~P 0.82; 5 K_Kg!g~!gll__ 4:~S;K1l!nK_ 
GR+GASVM 101 ± loo± 86.04± loo.4O± 100± 90.67± 
Ecilter+dApytKit~:R~;K1K~~ K_~;}~~ PK~~;KOg~SM_.._ ..~:~OKi..~K~_K 0; 100 5.62; 100 
IG+GASVM 100.3 ± 100 ± 84.30 ± 100.20 ± 100 ± 88.67 ± 
(Filter+GASVM) 8.02; UTg;1~~ T:U~;_UU:R~K_ ....?~~~!~OK l;_~~ 3.22; 9PK~~ 
ArecursiveGASVM 2.80± 100± 93.69± 12.0± 100± 91.33± 
[6] 1.32; 4~; 100 OKR~; 98.66 5.58; ~l 0; 100 5.49; 100 
GASVM- 2.1 ± 100 ± 94.16 ± 6.5 ± 100 ± 92 ± 
II+GASVM [5] . 0.32; 2 M;1MM~:~R;9U:~~KK_~KT!!~ 0; 100 8.20; 100 
GASVM-II [3] 10 ± 100 ± 59.33 ± 30 ± 100 ± 84.67 ± 
0; 10 0; 100 29.32; 97.32 0; 30 0; 100 6.33; 93.33 
4,418.5± 75.31 ± 85.84± 4,465.2± 94.74± 90±MOGASVM [4] 50.19; 4,433 0.99; 78.13 3.97; 93.29 18.34; 4,437 0; 94.74 3.51; 93.33 
GASVM [3] 6,267.8 ± 75 ± 84.77 ± 6,298.8 ± 94.74 ± 87.33 ± 
._. ~~:P~;_S_D~~~_ _M~TKR_~.K?_~;~O:~.. ~_~~gKK!K~~~~KKKM; 94.74. 2.11; 86.67 
12,533 ± 65.63 ± 85.91 ± 12,582 ± 92.98 ± 86.67 ± SVM classifier [4] 0; 12,533 0; 65.63 0; 85.91 0; 12,582 0; 92.98 0; 86.67 
Note: The best result ofeach data set shown in shaded cells. S.D. denotes the standard deviation, whereas #Genes 
represents a number of selected genes. 
Overall, this work has outperformed the related previous works on both the data sets 
in terms of classification accuracy and the number of selected genes. Filter+MOGASVM in 
our work has produced a near-optimal (smaller) gene subset from high-dimensional data and 
reduced the high risk of over-fitting problems. This is due to the fact that a filter method in 
the first stage of Filter+MOGASVM reduces the dimensionality of the solution space in order 
to produce a gene subset. Next, MOGASVM in the second stage of Filter+MOGASVM 
optimises the subset automatically to yield a smaller subset of informative genes with higher 
classification accuracy. This smaller subset is obtained since Filter+MOGASVM considers 
and optimises a relation among genes. 
4. CONCLUSIONS 
In this paper, Filter+MOGASVM has been proposed and tested for gene selection on two real 
microarray data sets that contain binary classes and multi-classes of tumour samples. Based 
on the experimental results, the performance ofFilter+MOGASVM was superior to the other 
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mative experimental methods and related previous works. This is due to the fact that the filter method 
in the first stage of the proposed method can pre-select genes and reduce dimensionality of 
data in order to produce a subset of genes. When the dimensionality was reduced, the 
us combination of genes and complexity of solution spaces were automatically decreased. The 
second stage of Filter+MOGASVM can automatically optimise the subset that is yielded by 
I: S.D.; the first stage. This optimisation process is done to remove irrelevant and noisy genes, and 
fmally produce a smaller (near-optimal) subset of informative genes. Hence, the gene 
selection using Filter+MOGASVM is needed to produce a smaller subset of informative 
genes for better cancer classification of microarray data. However, due to the application of a 
filter method in the first stage of Filter+MOGASVM, pre-selecting genes is difficult since it is 
manually done. Even though Filter+MOGASVM has classified tumours with higher accuracy, 
it is still not able to completely avoid the over-fitting problem. Therefore, a combination 
between constraint based reasoning methods and particle swarm optimisation techniques is 
recently developed to solve the over-fitting problem. 
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